NCT07111390View on ClinicalTrials.gov

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

March 1, 2026

Conditions
DepressionMDDMajor Depressive DisorderMajor Depressive Episode
Interventions
DEVICE

60Hz Intermittent Light Therapy

Intermittent 60 Hz flickering white light delivered via a wearable headset.

DEVICE

Sham Light Therapy

Constant white light delivered via a wearable headset.

Trial Locations (1)

10017

RECRUITING

NYU Langone Health, New York

All Listed Sponsors
collaborator

Syntropic Medical

UNKNOWN

lead

NYU Langone Health

OTHER

NCT07111390 - Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter